Affiliation:
1. the Departments of Physiology (Y.N., H.L.), Surgery (D.K.R., N.C.C., R.E.M., M.C.O.), and Medicine (D.J.P.), Columbia University College of Physicians and Surgeons, New York, NY.
Abstract
Prostaglandin E
1
(PGE
1
) is often added to the donor pulmonary flush solution to enhance clinical lung preservation for transplantation. Although PGE
1
is thought to act as a pulmonary vasodilator during the harvest period, the precise mechanism(s) of action whereby PGE
1
enhances lung preservation is unknown. Because cAMP levels decline in endothelial and vascular smooth muscle cells exposed to hypoxia, we hypothesized that a PGE
1
-mediated increase in cAMP levels within the preserved lungs might improve pulmonary vascular homeostasis following lung transplantation. Rat lungs demonstrated a time-dependent decline in cAMP levels during hypothermic storage, with cAMP levels significantly increased by PGE
1
supplementation (≈2-fold by 6 hours,
P
<.0005). To test whether augmenting cAMP levels may enhance lung preservation, experiments were performed using an orthotopic rat left lung transplant model. Compared with controls, supplementing the preservation solution with the membrane-permeable cAMP analogue dibutyryl-cAMP resulted in dose-dependent preservation enhancement, marked by reduced pulmonary vascular resistance (6.0-fold,
P
<.01), improved arterial oxygenation (3.0-fold,
P
<.01), reduced graft neutrophil infiltration (1.5-fold,
P
<.05), and improved recipient survival (7.0-fold,
P
<.005). Similar preservation enhancement was observed with another cAMP analogue (8-bromo-cAMP) or the phosphodiesterase inhibitor indolidan. Stimulating the cAMP second messenger system by PGE
1
supplementation resulted in marked hemodynamic benefits and improved recipient survival, in parallel with reduced graft neutrophil infiltration, vascular permeability, and platelet deposition. These beneficial effects of PGE
1
were abrogated by simultaneous administration of the cAMP-dependent protein kinase antagonist Rp-cAMPS. Although an arterial vasodilator (minoxidil) resulted in significant pulmonary vasodilation during harvest, it lacked other nonvasodilating effects of PGE
1
and resulted in poor preservation. These data show that harvest vasodilation by itself is insufficient to enhance lung preservation and that PGE
1
enhances lung preservation by stimulating the cAMP-dependent protein kinase and promoting nonvasodilatory mechanisms of pulmonary protection.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Reference52 articles.
1. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation.
2. Ignarro LJ. Pharmacology of endothelium-derived nitric oxide and nitrovasodilators. West J Med. 1991;154:51-62.
3. Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation
4. Pinsky DJ Stern DM. Hypoxia-induced modulation of endothelial cell function. In: Zikria B Oz MC Carlson RW eds. Reperfusion Injury and Clinical Capillary Leak. Mt Kisco NY: Futura Publishing; 1994:31-55.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献